Measures of tumor proliferative activity

Baserga R, Growth regulation of the PCNA gene. J Cell Sci 98: 433, 1991 Brandt L, Olsson H, Survival following combination chemotherapy in advanced high grade lymphomas: relation to proliferative activity of the lymphoma cells. Eur J Haematol 38: 437, 1987 Bravo R, Frank R, Blundell PA, MacDonald-Bravo H, Cyclin/PCNA is the auxiliary protein of DNA polymerase. Nature 326: 515, 1987 Burger PC, Shibata T, Kleihues P, The use of the monoclonal antibody Ki-67 in the identification of proliferating cells: application to surgical neuropathology. Am J Surg Pathol 10: 611, 1986 Celis JE, Madsen P, Nielsen S, Celis A, Nuclear patterns of cyclin (PCNA) antigen distribution subdivide S-phase in cultured cells-some applications of PCNA antibodies. Leuk Res 10: 237, 1986 Costa A, Bonadonna G, Villa E, et al, Labeling index as a prognostic marker in non-Hodgkin's lymphomas. J Natl Cancer Inst 66: 1, 1981 Dawson AE, Norton JA, Weinberg DS, Comparative assessment of proliferation and DNA content in breast carcinoma by image analysis and flow cytometry, Am J Pathol 135: 1115, 1990 Denekamp J, Kallsman RF, In vitro and in vivo labelling of animal tumors with tritiated thymidine. Cell Tissue Kinet 6: 217, 1973 Deshmukh P, Ramsey L, Garewal HS, Ki-67 labeling index is a more reliable measure of solid tumor proliferative activity than tritiated thymidine labeling. Am J Clin Pathol 94: 192, 1990 Dierendonck JH, Keijzer CJ, Van de Velde C, Cornelisse CJ, Nuclear distribution of the Ki-67 antigen during the cell cycle: comparison with growth fraction in human breast cancer cells. Cancer Res 49: 2999, 1989 Durie BG, Salmon SE, Moon TE, Pretreatment tumor mass, cell kinetics and prognosis in multiple myeloma, Blood 55: 364, 1980 Gerdes J, Schwab U, Lemke H, Stein H, Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer 31: 13, 1983 Gerdes J, Lemke H, Baisch H, et al, Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 133: 1710, 1984 Glotzer M, Murray AW, Kirschner MW, Cyclin is degraded by the ubiquitin pathway. Nature 349: 132, 1991 Gratzner HG, Monoclonal antibody to 5-bromo- and 5-iododeoxyuridine: a new reagent for detection of DNA replication. Science 218: 474, 1982 Greenberg B, Woo L, Blatchford S, Aguirre M, Garewal H, Variability of the thymidine labeling index in squamous cell carcinoma of the head and neck. Laryngoscope 98: 668, 1988 Grogan TM, Lippman SM, Spier CM, et al, Independent prognostic significance of a nuclear proliferation antigen in diffuse large cell lymphomas as determined by the monoclonal antibody Ki-67. Blood 71: 1157, 1988 Hall PA, Richards MA, Gregory WM, et al, The prognostic value of KI67 immunostaining in non-Hodgkin's lymphoma. J Pathol 154: 223, 1988 Hall PA, Levison DA, Woods AL, et al, Proliferating cell nuclear antigen (PCNA) Immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms. J Pathol 162: 285, 1990 Henderson IC, Prognostic factors. In: Harris JR, Hellman S, Henderson IC, Kinne DW (eds) Breast diseases. Lippincott, Philadelphia, p 332, 1991 Isola JJ, Heikki JH, Markku JH, Olli-Pekka K, Evaluation of cell proliferation in breast carcinoma: comparison of Ki-67 immunohistochemical study, DNA flow cytometric analysis, and mitotic count, Cancer 65: 1180, 1990 Isola J, Helin H, Kallioniemi O-P, Immunoelectron-microscopic localization of a proliferation-associated antigen Ki-67 in MCF-7 cells. Histochem J 22: 498, 1990 Jain S, Filipe MI, Hall PA, et al, Prognostic value of proliferating cell nuclear antigen in gastric carcinoma. J Clin Pathol 44: 655, 1991 Kamel OW, Franklin WA, Ringus JC, Meyer JS, Thymidine labeling index and Ki-67 growth fraction in lesions of the breast, Am J Pathol 134: 107, 1989 Kamel OW, LeBrun DP, Davis RE, et al, Growth fraction estimation of malignant lymphomas in formalin-fixed paraffin-embedded tissue using anti-PCNA/cyclin 19A2. Am J Pathol 138: 1471, 1991 Kaudewitz P, Braun-Falco O, Ernst M, et al, Tumor cell growth fractions in human malignant melanomas and the correlation to histopathologic grading. Am J Pathol 134: 1063, 1989 Levine MN, Browman GP, Gent M, Roberts R, Goodyear M, When is a prognostic factor useful? A guide for the perplexed. J Clin Oncol 9: 348, 1991 Matsushime H, Roussel M, Ashmun R, Sherr CJ, Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle. Cell 65: 701, 1991 Meyer JS, Conner RE, In vitro labeling of solid tissues with tritiated thymidine for autoradiographic detection of S-phase nuclei, Stain Technol 52: 185, 1977 Miyachi K, Fritzler MJ, Tan EM, Autoantibody to a nuclear antigen in proliferating cells. J Immunol 121: 2228, 1978 Parkins CS, Bush C, Price P, Stell GG, Cell proliferation in human tumour xenografts: measurement using antibody labelling against bromodeoxyuridine and Ki-67. Cell Prolif 24: 171, 1991 Pence JC, Kizilbash AM, Kerns BM, Proliferation index in various stages of breast cancer determined by Ki-67 immunostaining. J Surg Oncol 48: 11, 1991 Prelich G, Stillman B, Co-ordinated leading and lagging stand synthesis during SV40 DNA replication in vitro requires PCNA. Cell 53: 117, 1988 Prelich G, Tan CK, Kostura M, et al. Functional identity of proliferating cell nuclear antigen and a DNA polymerase δ auxiliary protein. Nature 326: 517, 1987 Quinn CM, Wright NA, The clinical assessment of proliferation and growth in human tumours: evaluation of methods and applications as prognostic variables. J Pathol 160: 93, 1990 Rao VVNG, Schnittger S, Hansmann I, Chromosomal localization of the human proliferating cell nuclear antigen (PCNA) gene to or close to 20p12 by in situ hybridization, Cytogenet Cell Genet 56: 169, 1991 Raza A, Spiridonidis C, Ucar K, et al, Double labeling of S-phase murine cells with bromodeoxyuridine and a second DNA-specific probe. Cancer Res 45: 2283, 1985 Raza A, Ucar K, Preisler HD, Double labeling in vitro versus in vivo incorporation of bromodeoxyuridine in patients with acute nonlymphocytic leukemia. Cytometry 6: 633, 1985 Raza A, Bokhari J, Yousuf N, et al, Cell cycle kinetic studies in human cancers, Arch Pathol Lab Med 115: 873, 1991 Sahin A, Ro J, Ro JY, et al, Ki-67 immunostaining in nodenegative stage I/II breast carcinoma. Cancer 68: 549, 1991 Schwarting R, Gerdes J, Niehus J, et al, Determination of the growth fraction in cell suspensions by flow cytometry using monoclonal antibody Ki-67. J Immunol Methods 90: 65, 1986 Schwartz BR, Pinkus G, Bacus S, et al, Cell proliferation in non-Hodgkin's lymphomas: digital analysis of Ki-67 antibody staining. Am J Pathol 134: 327, 1989 Sella A, Naggar A el, Ro JY, et al, Evidence of malignant features in histologically mature teratoma. J Urol 146: 1025, 1991 Silvestrini R, Daidone MG, Gasparini G, Cell kinetics as a prognostic marker in node-negative breast cancer. Cancer 56: 1982, 1985 Slymen DJ, Miller TP, Lippman SM, Immunobiologic factors predictive of clinical outcome in diffuse large-cell lymphoma. J Clin Oncol 8: 986, 1990 Takahashi H, Strutton GM, Parsons PG, Determination of proliferating fractions in malignant melanomas by anti-PCNA/cyclin monoclonal antibody. Histopathology 18: 221, 1991 Titus JL, Shorter RG, Labeling of human tumors with tritiated thymidine. Arch Pathol 79: 324, 1965 Veronese SM, Gambacorta M, Detection of Ki-67 proliferation rate in breast cancer. Am J Clin Pathol 95: 30, 1991 Vollmer E, Roessner A, Gerdes J, et al, Improved grading of bone tumors with the monoclonal antibody Ki-67. J Cancer Res Clin Oncol 112: 281, 1986 Walker RA, Camplejohn RS, Comparison of monoclonal antibody Ki-67 reactivity with grade and DNA flow cytometry of breast carcinomas. Br J Cancer 67: 281, 1988 Wilson GD, McNally NJ, Dunphy E, et al, The labelling index of human and mouse tumours assessed by bromodeoxyuridine staining in vitro and in vivo and flow cytometry. Cytometry 6: 641, 1985 Yamada Y, Murata K, Kamihira S, et al, Prognostic significance of the proportion of Ki-67 positive cells in adult T-cell leukemia. Cancer 67: 2605, 1991 Zehr RJ, Bauer TW, Marks KE, Weltevreden A, Ki-67 and grading of malignant fibrous histiocytomas. Cancer 66: 1984, 1990